Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuya Yamanaka

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Oncology Reports|November 4, 2009
Medical management of brain metastases from lung cancer (Review)Ryuya Yamanaka
Trends in Molecular Medicine|April 12, 2008
Cell- and peptide-based immunotherapeutic approaches for gliomaRyuya Yamanaka
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 4, 2009
[Medical management of primary central nervous system lymphoma refractory or resistant to standard of care treatment]Ryuya Yamanaka
Brain and Nerve = Shinkei Kenkyu No Shinpo|February 25, 2009
[Molecular-targeted therapy for malignant glioma]Ryuya Yamanaka
International Journal of Oncology|March 11, 2004
Alphavirus vectors for cancer gene therapy (review)Ryuya Yamanaka
Neurosurgical Review|February 14, 2009
Dendritic-cell- and peptide-based vaccination strategies for gliomaRyuya Yamanaka
Molecular Medicine Reports|April 9, 2011
Management of refractory or relapsed primary central nervous system lymphoma (Review)Ryuya Yamanaka
Current Opinion in Molecular Therapeutics|March 2, 2006
Novel immunotherapeutic approaches to gliomaRyuya Yamanaka
World Neurosurgery|May 24, 2017
Radiation-Induced Schwannomas and Neurofibromas: A Systematic ReviewRyuya Yamanaka, Azusa Hayano
Advances in Experimental Medicine and Biology|May 29, 2012
Dendritic cell vaccinesRyuya Yamanaka, Koji Kajiwara
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Oncology Reports|November 4, 2009
Medical management of brain metastases from lung cancer (Review)Ryuya Yamanaka
Trends in Molecular Medicine|April 12, 2008
Cell- and peptide-based immunotherapeutic approaches for gliomaRyuya Yamanaka
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 4, 2009
[Medical management of primary central nervous system lymphoma refractory or resistant to standard of care treatment]Ryuya Yamanaka
Brain and Nerve = Shinkei Kenkyu No Shinpo|February 25, 2009
[Molecular-targeted therapy for malignant glioma]Ryuya Yamanaka
International Journal of Oncology|March 11, 2004
Alphavirus vectors for cancer gene therapy (review)Ryuya Yamanaka
Neurosurgical Review|February 14, 2009
Dendritic-cell- and peptide-based vaccination strategies for gliomaRyuya Yamanaka
Molecular Medicine Reports|April 9, 2011
Management of refractory or relapsed primary central nervous system lymphoma (Review)Ryuya Yamanaka
Current Opinion in Molecular Therapeutics|March 2, 2006
Novel immunotherapeutic approaches to gliomaRyuya Yamanaka
World Neurosurgery|May 24, 2017
Radiation-Induced Schwannomas and Neurofibromas: A Systematic ReviewRyuya Yamanaka, Azusa Hayano
Advances in Experimental Medicine and Biology|May 29, 2012
Dendritic cell vaccinesRyuya Yamanaka, Koji Kajiwara
Pageof 9